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Precocious pubertyAbstract A 6-year-old boy presented with bilateral gynecomastia and breast tenderness. The con-
dition started since 1 year before medical consultation with gradual onset and progressive course of
breast enlargement and accelerated growth with no history of any nipple discharge. There was no
history of drug intake or chronic diseases. Investigations showed picture of pseudo precocious
puberty with advanced bone age, suppressed LH, FSH and high estradiol (E2). Adrenal precursors
(17 OHP, D4 A, DHEA, DHEAS) were normal with normal testosterone, cortisol, ACTH. Scrotal
U/S was normal while, abdominal U/S revealed right sided hypo echoic supra renal rounded solid
mass. Abdominal multi-slice CT with contrast was done and revealed a well-defined hypo dense
right adrenal mass with heterogeneous enhancement in the post contrast study showing attenuation
of about 25 HU in precontrast and 111 HU in post contrast which makes the mass suspicious of
malignancy. Chest X-ray was normal with no lymphadenopathy or pulmonary infiltrates. The diag-
nosis of feminizing adrenal neoplasm was confirmed and laparoscopic right adrenalectomy was
done. Microscopic examination was done after excision and revealed a picture of adrenocortical
adenoma with distinct cell borders with no vascular or capsular invasion. The hormonal profile
was repeated after 2 weeks of adrenalectomy and revealed normal levels of estradiol (E2), adrenal
precursors, FSH and LH. Adrenal tumors can be functional presenting with virilization, Feminiza-
tion, or Cushing’s syndrome. Feminizing adrenal tumors are rare tumors especially in pediatrics,
but should be excluded in cases presented with gynecomastia. The differentiation between benign
and malignant tumors may be difficult.
 2016 The Egyptian Pediatric Association. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Feminizing adrenal tumors (FAT) are very rare neoplasms
especially in children.1–3Adrenocortical tumors can be functional with varied endo-
crine syndromes; rapidly progressing Cushing’s syndrome, vir-
ilization or gynecomastia. When associated with gynecomastia
and overproduction of estrogen in men, the term feminizing
adrenal tumor is used.1,3
They can present with gynecomastia or breast tenderness
with or without other manifestations of gonadal deficiency.
A huge abdominal tumor may be observed. In children, they
induce pseudo precocious puberty (isosexual in females and
heterosexual in males).2
98 H.M. Soliman et al.In these neoplasms, the differentiation between adenoma
and carcinoma is usually difficult.1,4
Case presentation
History
A six year old boy presented with bilateral gynecomastia and
breast tenderness. The condition started one year before med-
ical consultation by gradual onset and progressive course of
breast enlargement and accelerated growth (in the form of
height gain mainly). There was no history of galactorrhea or
any nipple discharge. There was no history of drug intake or
chronic diseases. There were no similar conditions or obesity
in the family. Only he had a female sibling with Down
syndrome.
Examination
On examination, gynecomastia was the most prominent fea-
ture on examination: bilateral, symmetrical, around 10 cm
diameter with no focal lesions or palpable masses (Fig. 1a)
with no galactorrhea, and no axillary lymph nodes
enlargement.
He had pubic hair (Tanner stage P2), prepubertal testis (T3)
bilaterally (Fig. 1b) with no axillary hair.
Apart from high BMI, he had no other clinical manifesta-
tions of Cushing’s syndrome (no hirsutism, no striae with nor-
mal blood pressure).
Anthropometric measures: height: 125.6 cm (+2 SDS),
weight: 31 kg (+3.5 SDS), and BMI: 19.7 (+2.4 SDS).
Investigations
The diagnosis of pseudo precocious puberty was suspected, for
which the following investigations were done:
 X-ray left hand and wrist for bone age revealed bone age of
8 years (advanced).
 Abdominal and breast U/S showed:Figure 1 It shows bilateral gynecomastia which was the prese– Right sided supra renal rounded solid mass; 23  18 -
mms, hypo echoic related to the upper pole of the right
kidney and lies posterior to the liver.
– Right breast disc 24  13 mms.
– Left breast disc 22  14 mms.
 Scrotal U/S (Fig. 2):
– Both testis of average sizes with homogenous even echo-
texture.
– Right testis: 23  11 mms.
– Left testis: 22  11 mms.
 Hormonal profile was done to exclude central and adrenal
causes of precocious puberty (Table 1).
 LHRH stimulation test revealed suppressed gonadotropins
suggesting pseudo precocious puberty:
– FSH (basal): <0.1 ml U/ml.
– FSH (after 4 h): <0.1 ml U/ml.
– LH (basal): 0.1 ml U/ml.
– LH (after 4 h): 0.2 ml U/ml.
 Cushing’s syndrome couldn’t be ruled out as however, 24 h
urinary cortisol was normal (147 l/d), with normal HbA1c
(5.1%), and normal fasting and post prandial blood glu-
cose, serum cortisol was not suppressed by single dose dex-
amethasone suppression (serum cortisol: 12.3 l/dl).
 Other investigations revealed normal serum sodium
(139 meq/l), normal serum potassium (4.2 meq/l) with nor-
mal renal and liver functions.
 Chest X-ray was done to exclude metastasis and was nor-
mal with no lymphadenopathy or pulmonary infiltrates.
 Abdominal multi-slice C.T with oral and IV contrast
administration was done and revealed: A well-defined hypo
dense right adrenal mass measuring 2.3  1.7  2 cm with
heterogeneous enhancement in the post contrast study
showing attenuation of about 25 Hounsfield units (HU) in
precontrast and 111 HU in post contrast (Fig. 3).
Intervention
The diagnosis of feminizing adrenal neoplasm was confirmed
and the decision to do laparoscopic right adrenalectomy wasnting symptom (a), and the pubic hair, tanner stage 2 (b).
Figure 2 It represents the scrotal U/S and shows normal testicular size and echogenicity.
Table 1 Hormonal profile pre and post-operative.
Investigation Pre-operative Post-operative Normal values
Estradiol (E2) pg/ml 32 5 Up to 15
Testosterone (free) pg/ml 0.52 0.4 0.3–0.5
Testosterone (total) ng/ml 0.3 0.2 0.1–0.4
FSH (basal) ml U/ml <0.1 1.4 0.5–3.5
LH (basal) ml U/ml 0.1 2.2 1–4
Prolactin (ng/ml) 6.7 17 2.1–17.7
D4 Androstenedione (ng/ml) <0.3 <0.3 Up to 0.5
DHEA (ng/ml) 0.66 <0.1 1.5–9
DHEA-S (l/dl) 48.4 <15 Up to 280
Cortisol (am) l/dl 49.4 5–22
Cortisol (pm) l/dl 3.6 3–16.6
ACTH (am) pg/ml 49.4 Up to 50
ACTH (pm) pg/ml 18.5 Up to 30
17 OH progesterone (ng/ml) 0.9 0.42 0.5–2.4
Serum aldosterone (l/dl) 11 5–80
Plasma renin activity (PRA) ng/ml/hr 4 0.5–6.5
FSH: follicle stimulating hormone, LH: luteinizing hormone, DHEA: dehydroepiandrosterone, DHEA-S: dehydroepiandrosterone Sulfate,
ACTH: Adrenocorticotropic hormone.
Figure 3 It represents the abdominal multi-slice C.T with
contrast showing the well-defined right adrenal hypo dense mass.
Feminizing adrenal tumor 99taken after surgical consultation as it was considered the main-
stay of treatment.5
The patient did the routine preoperative investigations as
complete blood count, coagulation profile, liver and kidney
function. All were normal.
Regarding the preoperative preparations, he received single
preoperative dose of hydrocortisone (100 mg) once at the onset
of the operation with monitoring of: blood pressure, blood
glucose, and serum electrolytes (Na and K).
The operative details
The first 1.5 cm incision was made just below the tip of the
12th rib (Fig. 4a). Blunt dissection was performed medially
and laterally with the index finger inside the retroperitoneal
space.
The dissection started by entering Gerota’s fascia to iden-
tify the superior pole of the kidney. The adrenal vein was then
Figure 4 It shows intra-operative photos with the incisions in the prone position (a) and the mass appearing with right adrenal vein
identification (b).
Figure 5 It represents an intra-operative photo for the mass after
excision.
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was then dissected free from the remaining attachments and
extracted through the middle trocar and the wound was closed.Figure 6 It represents the microscopic examination of the mass with t
invasion and distinct cell borders.He received intravenous fluids for 24 h post operatively
and then started oral feeding, in addition to, low dose
hydrocortisone (20 mg/m2/d) for 3 days with monitoring of
blood pressure, blood glucose, and serum electrolytes (Na
and K).
The boy passed uncomplicated post-operative course and
the hydrocortisone was discontinued on the 4th day.
The specimen was sent for pathology study which revealed
the following:
Description:
Gross: a well circumscribed capsulated soft mass;
2.5  2  1 cm, with soft homogenous brownish yellow cut
section (Fig. 5).
Microscopic: capsulated growth formed of large cells with
distinct cell borders and variable sized nuclei and abundant
eosinophilic cytoplasm. No evidence of capsular or vascular
invasion (Fig. 6).
Diagnosis: adrenocortical adenoma.
After 2 weeks, the hormonal profile was repeated and
revealed normal levels of estradiol (E2), adrenal precursors,
FSH and LH (Table 1).he picture of adrenocortical adenoma with no capsular or vascular
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Feminizing adrenal tumors are very rare. Only few cases have
been reported. Most of the reported cases were adrenal
carcinomas.2,4,6
Gynecomastia with no galactorrhea is usually the present-
ing symptom. It is usually bilateral and painful at first.2 Other
symptoms of pseudo precocious puberty with accelerated
growth and advanced bone age can be associated as in our
case.
Regarding the investigations, feminizing adrenal tumors
may present with normal DHEA-S as in our case. A high level
of estrogen causes gonadotropin suppression by negative feed-
back mechanism causing low FSH and LH. After adrenalec-
tomy the pituitary will be released from suppression
increasing the levels of FSH and LH to their normal levels
as in this case.
Although adenomas are typically smaller (usually
<4 cm), more homogenous with well-defined margins,
small metastases may be homogeneous and with well-
defined margins.7 Unenhanced CT can help to differentiate
adenomas from metastasis as most adenomas lower attenu-
ation values than metastasis on unenhanced CT. With a
cut-off attenuation value of 10 HU, sensitivity of 71%
and a specificity of 98% were found.8,9 On the other hand,
Park et al. suggested a higher threshold of 20 or 25 HU
which provided a specificity and sensitivity of 100% and
60%, respectively.10
The presence of certain pathologic criteria involving mitotic
activity, capsular necrosis, hemorrhage or calcification leans
more to the diagnosis of carcinoma.1,11 Histological predictive
factors for malignancy are classified on three stages. The
tumor is considered as malignant if there are more than four
suspect signs which are: Large nuclei, mitotic index more than
5/50, atypical mitosis, less than 25% light cells, capsular inva-
sion, necrosis, diffuse architecture (>33%), sinusoidal inva-
sion, and vascular embolism.12
In this case, the adrenal mass was suspicious of malignancy
as although it was small, with well-defined edges, it showed
heterogeneous enhancement on the enhanced post contrast
CT. Moreover, it had high attenuation values (25 HU on the
unenhanced CT and 111 HU on the enhanced CT). The diag-
nosis of a benign adrenal adenoma was proved by biopsy
which showed distinct borders, with no capsular or vascular
invasion.Conclusion
Feminizing adrenal tumors (FAT) are rare, but should be
excluded in cases of gynecomastia. Appropriate management
is important to rule out malignancy. Laparoscopic adrenalec-
tomy is the mainstay of treatment.
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